Clinical evaluation of teprenone, a mucosal protective agent, in the treatment of patients with gastric ulcers: a nationwide, multicenter clinical study.
暂无分享，去创建一个
[1] K. Ogoshi. Gastric Ulcer Relapse , 1994 .
[2] E Hentschel,et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. , 1993, The New England journal of medicine.
[3] P D Klein,et al. Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal Ulcer , 1992, Annals of Internal Medicine.
[4] N. Takeyama,et al. Changes in gastric mucosal content of adenosine, xanthine and hypoxanthine induced by restrained water immersion stress: antiulcer effects of tetraprenylacetone. , 1991, Digestion.
[5] A. Terano,et al. Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. , 1986, Digestion.
[6] A. Terano,et al. Protective action of tetraprenylacetone against ethanol-induced damage in rat gastric mucosa. , 1986, Digestion.
[7] E. Rogers,et al. Clinical failures with cimetidine. , 1980, Surgery.